Model N Acquires Kalderos to Expand 340B and Gross-to-Net Revenue Management

Model N announced it has acquired Kalderos, a technology company that provides gross-to-net intelligence for 340B drug discount programs. The acquisition expands Model N’s end-to-end life sciences commercialization and revenue management platform, adding Kalderos’ Truzo claims-level visibility to improve 340B compliance monitoring, claim validation, and dispute resolution.